EU
GEVA

Emory University’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Emory University’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,854
Closed -$961K – 24
2015
Q1 		$961K Buy
+9,854
New +$1.04M 1.82% 8

Emory University's GEVA Position: Q2 2015 in Review

Emory University sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 9,854 shares — an estimated $961K sold.

Emory University first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $961K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Emory University reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Emory University sold 9,854 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $961K.
  • Emory University first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Emory University's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $961K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Emory University's 13F filing for Q2 2015, filed 13 Aug 2015.